Atrial fibrillation update 1996: Case II

Cardiovascular Reviews and Reports

Volumn 17, Issue 7, 1996, Pages

  Reiffel, James A ^a,c   Haffajee, Charles I ^b,d  

^a Department of Clinical Medicine ^*

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; PROPAFENONE; QUINIDINE; QUINIDINE GLUCONATE; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; WARFARIN;

AGED; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTICLE; CARDIOVERSION; CASE REPORT; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; QT INTERVAL;

EID: 8944230183     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Alderman EL, Bourassa MG, Cohen LS, et al Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation. 1990;82:1629-1646.
2. Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321.406-412.
3. Furberg CD. Effect of antiarrhythmic drugs on mortality after myocardial infarction. Am J Cardiol. 1983;52:32C-36C.
4. Flaker GC, Blackshear JL, McBride R, et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 1992;20:527-532.
5. Niwano S, Ortiz J, Abe H, et al. Characterization of the excitable gap in a functionally determined reentrant circuit. Studies in the sterile pericarditis model of atrial flutter. Circulation. 1994;90:1997-2014.
6. Capucci A, Boriani G, Botto GL, et al. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol. 1994;74:503-505.
7. Mason JW, for the Electrophysiologic Study Versus Electrocardiographic Monitoring Investigators. A comparison of electrophysiologic testing with Holter monitoring to reduce antiarrhythmic drug efficacy for ventricular tacharrhythmias. N Engl J Med. 1993;329:445-451.
8. Arnold AZ, Mick MJ, Mazurek RP, et al. Role of prophylactic anticoagulation on patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol. 1992;19:851-855.